Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × FED × Prostate Cancer Diagnosis × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Prostate Cancer Diagnosis 1 Patient Compliance 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Diseases, Obstructive 1 Kidney Diseases 1 Keratosis, Actinic 1 Glioma 1 Glioblastoma 1 Dementia 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1

Interventions

2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05820724 2023-04-24

PSMA PET Scan and mpMRI for Prostate Cancer Detection

VA Greater Los Angeles Healthcare System

Phase 2 Not yet recruiting

Prostate Cancer Diagnosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡